Blaze Bioscience Secures $8,080,400 Series B Funding

  • Feed Type
  • Date
    6/28/2013
  • Company Name
    Blaze Bioscience
  • Mailing Address
    530 Fairview Avenue North Seattle, WA 98109
  • Company Description
    Blaze Bioscience was founded in 2010 to develop and commercialize Tumor Paint technology, which has the potential to fundamentally transform surgical oncology.
  • Website
    http://www.blazebioscience.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,080,400
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.